Cadeltro 50mg Tablet

About

This medication is a targeted anti-cancer agent designed to selectively interfere with the growth and proliferation of malignant cells within the body. It operates through specific molecular mechanisms, which may involve inhibiting key enzymes, blocking receptor pathways crucial for tumor survival, or disrupting cellular processes essential for cancer cell division and metastasis. By precisely targeting these vulnerabilities, the drug aims to minimize harm to healthy cells while maximizing its cytotoxic effects on cancerous ones.

As an integral component of a comprehensive cancer treatment strategy, this agent is employed to reduce tumor burden, prevent disease progression, and improve overall patient outcomes. Its therapeutic efficacy is often evaluated in the context of specific cancer types and stages, where it contributes to achieving remission or extending progression-free survival. The precise mode of action and clinical application are tailored to the specific cancer being addressed, reflecting advancements in personalized oncology.

Uses

• Various solid tumors
• Hematological malignancies
• Adjuvant therapy post-surgery
• Palliative treatment for advanced cancer

Directions For Use

Take orally as prescribed by your oncologist. Follow the dosage and schedule carefully, with or without food.

Benefits

• Targets specific cancer cell pathways
• Can reduce tumor size and progression
• May improve disease-free survival
• Oral formulation for ease of use
• Part of multi-modal cancer therapy
• Potential to extend life expectancy

Side Effects

• Nausea and vomiting
• Fatigue
• Diarrhea or constipation
• Hair thinning
• Myelosuppression
• Skin rash
• Peripheral neuropathy
• Liver enzyme elevation
• Mouth sores
• Loss of appetite
• Headache
• Muscle or joint pain

Safety Measures

• Alcohol - Avoid or limit alcohol consumption as it may exacerbate side effects or increase liver toxicity.
• Pregnancy - Contraindicated in pregnancy due to high risk of fetal harm. Use highly effective contraception during and after treatment.
• Breastfeeding - Not recommended during breastfeeding as the drug can pass into breast milk and potentially harm the infant.
• Liver - Use with caution in patients with hepatic impairment; monitor liver function tests closely and adjust dose as necessary.
• Kidney - Use with caution in patients with renal impairment; dosage adjustments may be required based on kidney function.
• Lung - Monitor for any new or worsening respiratory symptoms, as some anti-cancer agents can cause pulmonary toxicity.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.